The Company is engaged in develop, market and distribute medical equipment, principally the laryngeal mask airway line of products. LMA designs, develops, markets and distributes medical equipment, principally the LMATM laryngeal mask airway range of supraglottic airway management devices. These devices are used by physicians to allow respiration, provide ventilation to, and support the airway of patients undergoing surgical procedures and life-saving interventions. LMA has an office in Jersey, Channel Islands, and subsidiaries in Singapore, Bonn, Germany, San Diego, California and Melbourne, Australia. Through its 50 percent joint venture in LMA Urology Limited, the Group has a subsidiary in Switzerland to design, manufacture and distribute the LMA StoneBreakerTM. DBS Bank and Credit Suisse were the Joint Global Coordinators and Joint Bookrunners for the Initial Public Offering of shares in LMA.This company is established in Netherlands
7-A Abraham De Veerstraat
Contact Details: Purchase the Lma International N.V. (Willemstad) report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service